PL1680089T3 - Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków - Google Patents

Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków

Info

Publication number
PL1680089T3
PL1680089T3 PL04790845T PL04790845T PL1680089T3 PL 1680089 T3 PL1680089 T3 PL 1680089T3 PL 04790845 T PL04790845 T PL 04790845T PL 04790845 T PL04790845 T PL 04790845T PL 1680089 T3 PL1680089 T3 PL 1680089T3
Authority
PL
Poland
Prior art keywords
composition
drug delivery
controlled drug
biodegradable hydrating
hydrating ceramics
Prior art date
Application number
PL04790845T
Other languages
English (en)
Inventor
Hans Lennernäs
Bo Lennernäs
Jonas Hugosson
Niklas Axen
Original Assignee
Lidds Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0302782A external-priority patent/SE0302782D0/xx
Application filed by Lidds Ab filed Critical Lidds Ab
Publication of PL1680089T3 publication Critical patent/PL1680089T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04790845T 2003-10-22 2004-10-21 Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków PL1680089T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0302782A SE0302782D0 (sv) 2003-10-22 2003-10-22 Composition for sustained drug delivery
US56187504P 2004-04-14 2004-04-14
EP04790845.4A EP1680089B1 (en) 2003-10-22 2004-10-21 Composition comprising biodegradable hydrating ceramics for controlled drug delivery
PCT/EP2004/012060 WO2005039537A1 (en) 2003-10-22 2004-10-21 Composition comprising biodegradable hydrating ceramics for controlled drug delivery

Publications (1)

Publication Number Publication Date
PL1680089T3 true PL1680089T3 (pl) 2014-03-31

Family

ID=34525629

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04790845T PL1680089T3 (pl) 2003-10-22 2004-10-21 Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków

Country Status (4)

Country Link
US (2) US8124118B2 (pl)
EP (1) EP1680089B1 (pl)
PL (1) PL1680089T3 (pl)
WO (1) WO2005039537A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US7297247B2 (en) * 2003-05-06 2007-11-20 Applied Materials, Inc. Electroformed sputtering target
US8124118B2 (en) 2003-10-22 2012-02-28 Lidds Ab Composition comprising biodegradable hydrating ceramics for controlled drug delivery
CA2602776C (en) 2005-03-31 2013-10-22 Lidds Ab Method for treating prostate diseases based on local delivery of active substances
ATE460154T1 (de) * 2006-03-14 2010-03-15 Lidds Ab Bioresorbierbare zusammensetzung mit kontrollierter freisetzung
EP2376135B1 (en) * 2008-11-27 2015-05-27 Lidds Ab Use of carboxymethylcellulose to control ejectability and solidification time of compositions comprising one or more bioresorbable ceramics
EP2396037A4 (en) * 2009-02-12 2012-12-19 Aduro Material Ab COMPOSITION WITH A BIODEGRADABLE CARRIER FOR THE CONTROLLED DISPOSAL OF MEDICAMENTS
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2756301T3 (es) 2014-08-19 2020-04-27 Univ California Implantes de administración localizada de fármacos y métodos de uso de los mismos
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10907022B2 (en) * 2015-10-02 2021-02-02 Imerys Usa, Inc. Controlled polymer foaming by tuning surface interactions between blowing agents and minerals
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CN110869065B (zh) * 2017-04-13 2022-07-01 塞普托东专业股份有限公司 包含硅酸钙的结缔组织例如骨、牙本质或牙髓再生材料
WO2019170912A1 (en) 2018-03-09 2019-09-12 Lidds Ab Bioresorbable controlled-release compositions with sting modulating molecules
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US20240100010A9 (en) * 2020-03-20 2024-03-28 The Regents Of The University Of California Implantable Drug Delivery Devices For Localized Drug Delivery
US11338119B2 (en) 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218255A (en) 1976-08-30 1980-08-19 University Of Dayton Porous ceramic carriers for controlled release of proteins, polypeptide hormones, and other substances within human and/or other mamillian species and method
EP0061108B1 (de) 1981-03-19 1986-12-30 mundipharma GmbH Knochenimplantat aus Tricalciumphosphat mit mikro-und makroporöser Struktur, Verfahren zu seiner Herstellung und seiner Verwendung
NL8401061A (nl) 1984-04-04 1985-11-01 Stichting Biomaterials Science Werkwijze voor het bereiden van een implantatiemateriaal dat geneesmiddelen afgeeft in het lichaam.
US4891225A (en) 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
DE3671375D1 (de) 1985-02-19 1990-06-28 Dow Chemical Co Hartgewebeprothese und verfahren zu ihrer herstellung.
US5164186A (en) * 1988-10-13 1992-11-17 Kabushikigaisha Ars Japan Drug-releaser
EP0376331A3 (en) 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5156623A (en) 1990-04-16 1992-10-20 Olympus Optical Co., Ltd. Sustained release material and method of manufacturing the same
JP2538134B2 (ja) 1991-04-08 1996-09-25 田辺製薬株式会社 徐放性製剤およびその製造法
US5162117A (en) * 1991-11-22 1992-11-10 Schering Corporation Controlled release flutamide composition
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
US5614206A (en) 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
US8333996B2 (en) * 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US5683725A (en) 1995-05-25 1997-11-04 Biofrontiers, Inc. Modulation of substance P by compounds containing calcium sulfate and methods relating thereto
DE19620117C1 (de) 1996-05-18 1997-07-24 Corimed Kundenorientierte Medi Verfahren zur Herstellung eines calciumsulfathaltigen medizinischen Präparats und calciumsulfathaltiges medizinisches Präparat
FR2749756B1 (fr) 1996-06-14 1998-09-11 Bioland Procede de preparation d'un materiau composite implantable, materiau obtenu, implant comprenant ce materiau et kit de mise en oeuvre
US5756127A (en) 1996-10-29 1998-05-26 Wright Medical Technology, Inc. Implantable bioresorbable string of calcium sulfate beads
WO1998023556A1 (en) * 1996-11-25 1998-06-04 Kabushiki Kaisya Advance Method of production of ceramics
US6391336B1 (en) 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
KR100293504B1 (ko) 1998-06-05 2001-07-12 김윤 서방형전립선염치료제조성물
CA2360938C (en) 1999-02-02 2008-01-08 Warren Oliver Haggard Controlled release composite
GB9916601D0 (en) 1999-07-16 1999-09-15 Biocomposites Ltd Calcium sulphate
DE19953771C1 (de) 1999-11-09 2001-06-13 Coripharm Medizinprodukte Gmbh Resorbierbares Knochen-Implantatmaterial sowie Verfahren zur Herstellung desselben
US6479418B2 (en) * 1999-12-16 2002-11-12 Isotis N.V. Porous ceramic body
EP1155704A1 (en) 2000-01-13 2001-11-21 Chih-I Lin Orthopedic filling material and method of use thereof
US6770695B2 (en) 2000-08-07 2004-08-03 John L. Ricci Time release calcium sulfate matrix for bone augmentation
WO2002041844A2 (en) * 2000-10-20 2002-05-30 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
US6497901B1 (en) * 2000-11-02 2002-12-24 Royer Biomedical, Inc. Resorbable matrices for delivery of bioactive compounds
GB0110726D0 (en) 2001-05-02 2001-06-27 Biocomposites Ltd Bone implant composition
WO2003011214A2 (en) 2001-07-31 2003-02-13 Royer Biomedical, Inc. Novel methods and formulations for administration of active agents
US20030158598A1 (en) * 2001-09-17 2003-08-21 Control Delivery Systems, Inc. System for sustained-release delivery of anti-inflammatory agents from a coated medical device
AU2002327007B2 (en) 2001-09-21 2005-10-20 Stryker Corporation Pore-forming agents for orthopedic cements
DK1461017T3 (da) 2001-11-19 2006-06-19 Lupin Ltd Farmaceutisk sammensætning til styret frigivelse af et beta-lactam-antibiotikum
GB0200051D0 (en) 2002-01-03 2002-02-20 Biocomposites Ltd Biodegradable implant materials
GB0201031D0 (en) 2002-01-17 2002-03-06 Bookham Technology Plc Method of producing a rib waveguide
US20030180344A1 (en) * 2002-02-05 2003-09-25 Cambridge Scientific, Inc. Bioresorbable osteoconductive compositions for bone regeneration
US20030147936A1 (en) 2002-02-07 2003-08-07 Velayudhan Sahadevan Prostatic hormonal implants treatment of prostate cancer
US7163965B2 (en) 2002-05-01 2007-01-16 Japan Science And Technology Agency Process for producing porous composite materials
AU2003243608A1 (en) 2002-06-20 2004-01-06 Royer Biomedical, Inc. Resorbable delivery systems for the treatment of cancer
US20050266077A1 (en) 2002-06-20 2005-12-01 Royal Biomedical, Inc. Resorbable matrices with coatings for delivery of bioactive compounds
CA2500222A1 (en) 2002-09-30 2004-04-08 Regen Biotech, Inc. Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers
US8124118B2 (en) 2003-10-22 2012-02-28 Lidds Ab Composition comprising biodegradable hydrating ceramics for controlled drug delivery

Also Published As

Publication number Publication date
EP1680089B1 (en) 2013-09-11
EP1680089A1 (en) 2006-07-19
US9034359B2 (en) 2015-05-19
WO2005039537A1 (en) 2005-05-06
US8124118B2 (en) 2012-02-28
US20120219601A1 (en) 2012-08-30
US20090036392A1 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
PL1680089T3 (pl) Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków
EP1615621A4 (en) COMPOSITIONS FOR ADMINISTERING DRUG COMBINATIONS
GB0310300D0 (en) Nanocomposite drug delivery composition
IL161214A0 (en) Compositions for delivery of drug combinations
IL174690A0 (en) Enhanced drug delivery
IL172620A0 (en) Intravaginal drug delivery devices
AU2003237288A1 (en) Biodegradable block copolymeric compositions for drug delivery
IL164031A (en) Compositiion having gelling properaties for the prolonged delivery of bioactive substances
EP1648338A4 (en) COMPOSED RESORBIBLE / BIODEGRADABLE RINGS FOR CHECKING THE MEDICINAL PRODUCT
PL1631255T3 (pl) System dostarczania leków
GB0300427D0 (en) Pharmaceutical composition
ZA200505274B (en) Pharmaceutical compositions comprising fentanyl for intranasal delivery
IL151910A0 (en) Compositions for drug delivery
EP1694278A4 (en) GLP-1 PHARMACEUTICAL COMPOSITIONS
GB0304636D0 (en) Pharmaceutical composition for nasal delivery
AP2006003602A0 (en) Oral drug delivery system
EP1699458A4 (en) PHARMACEUTICAL COMPOSITION
IL172814A0 (en) Novel solid pharmaceutical composition comprising amisulpride
AU2003272127A1 (en) Polymeric composition for drug delivery
GB0300885D0 (en) Pharmaceutical composition
GB0306933D0 (en) Pharmaceutical composition
EP1696886A4 (en) METHODS AND COMPOSITIONS FOR DELIVERY OF DRUGS
DK1680089T3 (da) Sammensætning omfattende bionedbrydelige hydrerende keramikstoffer til kontrolleret lægemiddelafgivelse
HU0200337D0 (en) Stabilised pharmaceutical composition
GB2405094B (en) Pharmaceutical composition for controlled drug delivery system